Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 3-Month, Randomised, Open-Label, Parallel-Group, Descriptive Study To Explore And Compare Perceptions and Satisfaction For Two Different Delivery Mechanisms For Etanercept (Etanercept Autoinjector And The Etanercept Prefilled Syringe) In Patients With Rheumatoid Arthritis

NCT00459706 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00459706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00459706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 3-Month, Randomised, Open-Label, Parallel-Group, Descriptive Study To Explore And Compare Perceptions and Satisfaction For Two Different Delivery Mechanisms For Etanercept (Etanercept Autoinjector And The Etanercept Prefilled Syringe) In Patients With Rheumatoid Arthritis
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2007
Completion date
September 30, 2009
Enrollment
640 (actual)
Sites
113

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis